119 related articles for article (PubMed ID: 37625512)
1. Amino acid profiling as a screening and prognostic biomarker in active tuberculosis patients.
Sun Y; Liao Y; Xiong N; He X; Zhang H; Chen X; Xiao G; Wang Z; Rao W; Zhang G
Clin Chim Acta; 2023 Aug; 548():117523. PubMed ID: 37625512
[TBL] [Abstract][Full Text] [Related]
2. Discovering novel biomarkers for diagnosis and treatment monitoring of active pulmonary tuberculosis by ion metabolism analysis.
Feng Q; Lin Q; Yao F; Liao Y; Zhang H; Sun Y; Liu W; Zhang R; Rao W; Zhang G; Xu Y
Microbiol Res; 2024 Jun; 283():127670. PubMed ID: 38479231
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers of iron metabolism facilitate clinical diagnosis in
Dai Y; Shan W; Yang Q; Guo J; Zhai R; Tang X; Tang L; Tan Y; Cai Y; Chen X
Thorax; 2019 Dec; 74(12):1161-1167. PubMed ID: 31611342
[TBL] [Abstract][Full Text] [Related]
4. Plasma immune profiling combined with machine learning contributes to diagnosis and prognosis of active pulmonary tuberculosis.
Yao F; Zhang R; Lin Q; Xu H; Li W; Ou M; Huang Y; Li G; Xu Y; Song J; Zhang G
Emerg Microbes Infect; 2024 Dec; 13(1):2370399. PubMed ID: 38888093
[TBL] [Abstract][Full Text] [Related]
5. Metabolomic Profiling of Plasma from Patients with Tuberculosis by Use of Untargeted Mass Spectrometry Reveals Novel Biomarkers for Diagnosis.
Lau SK; Lee KC; Curreem SO; Chow WN; To KK; Hung IF; Ho DT; Sridhar S; Li IW; Ding VS; Koo EW; Wong CF; Tam S; Lam CW; Yuen KY; Woo PC
J Clin Microbiol; 2015 Dec; 53(12):3750-9. PubMed ID: 26378277
[TBL] [Abstract][Full Text] [Related]
6. Analysis of serum metabolic profile by ultra-performance liquid chromatography-mass spectrometry for biomarkers discovery: application in a pilot study to discriminate patients with tuberculosis.
Feng S; Du YQ; Zhang L; Zhang L; Feng RR; Liu SY
Chin Med J (Engl); 2015 Jan; 128(2):159-68. PubMed ID: 25591556
[TBL] [Abstract][Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
8. Interferon gamma release assays for Diagnostic Evaluation of Active tuberculosis (IDEA): test accuracy study and economic evaluation.
Takwoingi Y; Whitworth H; Rees-Roberts M; Badhan A; Partlett C; Green N; Boakye A; Lambie H; Marongiu L; Jit M; White P; Deeks JJ; Kon OM; Lalvani A
Health Technol Assess; 2019 May; 23(23):1-152. PubMed ID: 31138395
[TBL] [Abstract][Full Text] [Related]
9. Identification of potential lipid biomarkers for active pulmonary tuberculosis using ultra-high-performance liquid chromatography-tandem mass spectrometry.
Han YS; Chen JX; Li ZB; Chen J; Yi WJ; Huang H; Wei LL; Jiang TT; Li JC
Exp Biol Med (Maywood); 2021 Feb; 246(4):387-399. PubMed ID: 33175608
[TBL] [Abstract][Full Text] [Related]
10. Combining metabolome and clinical indicators with machine learning provides some promising diagnostic markers to precisely detect smear-positive/negative pulmonary tuberculosis.
Hu X; Wang J; Ju Y; Zhang X; Qimanguli W; Li C; Yue L; Tuohetaerbaike B; Li Y; Wen H; Zhang W; Chen C; Yang Y; Wang J; Chen F
BMC Infect Dis; 2022 Aug; 22(1):707. PubMed ID: 36008772
[TBL] [Abstract][Full Text] [Related]
11. Discovery and validation of a prognostic proteomic signature for tuberculosis progression: A prospective cohort study.
Penn-Nicholson A; Hraha T; Thompson EG; Sterling D; Mbandi SK; Wall KM; Fisher M; Suliman S; Shankar S; Hanekom WA; Janjic N; Hatherill M; Kaufmann SHE; Sutherland J; Walzl G; De Groote MA; Ochsner U; Zak DE; Scriba TJ;
PLoS Med; 2019 Apr; 16(4):e1002781. PubMed ID: 30990820
[TBL] [Abstract][Full Text] [Related]
12. Mass Spectrometry-Based Proteomic and Metabolomic Profiling of Serum Samples for Discovery and Validation of Tuberculosis Diagnostic Biomarker Signature.
Fernandes AF; Gonçalves LG; Bento M; Anjo SI; Manadas B; Barroso C; Villar M; Macedo R; Simões MJ; Coelho AV
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430211
[TBL] [Abstract][Full Text] [Related]
13. Metabolic phenotyping and global functional analysis facilitate metabolic signature discovery for tuberculosis treatment monitoring.
Anh NK; Yen NTH; Tien NTN; Phat NK; Park YJ; Kim HS; Vu DH; Oh JY; Kim DH; Long NP
Biochim Biophys Acta Mol Basis Dis; 2024 Apr; 1870(4):167064. PubMed ID: 38342417
[TBL] [Abstract][Full Text] [Related]
14. A Pilot Study for Investigation of Plasma Amino Acid Profile in Neurofibromatosis Type 1 Patients.
Oz O; Koyuncu I; Gonel A
Comb Chem High Throughput Screen; 2022; 25(1):114-122. PubMed ID: 33280590
[TBL] [Abstract][Full Text] [Related]
15. Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV-positive adults.
Shah M; Hanrahan C; Wang ZY; Dendukuri N; Lawn SD; Denkinger CM; Steingart KR
Cochrane Database Syst Rev; 2016 May; 2016(5):CD011420. PubMed ID: 27163343
[TBL] [Abstract][Full Text] [Related]
16. l-Histidine, arachidonic acid, biliverdin, and l-cysteine-glutathione disulfide as potential biomarkers for cured pulmonary tuberculosis.
Yi WJ; Han YS; Wei LL; Shi LY; Huang H; Jiang TT; Li ZB; Chen J; Hu YT; Tu HH; Li JC
Biomed Pharmacother; 2019 Aug; 116():108980. PubMed ID: 31125821
[TBL] [Abstract][Full Text] [Related]
17. Xpert
Kohli M; Schiller I; Dendukuri N; Dheda K; Denkinger CM; Schumacher SG; Steingart KR
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012768. PubMed ID: 30148542
[TBL] [Abstract][Full Text] [Related]
18. Blood Transcriptional Biomarkers for Active Tuberculosis among Patients in the United States: a Case-Control Study with Systematic Cross-Classifier Evaluation.
Walter ND; Miller MA; Vasquez J; Weiner M; Chapman A; Engle M; Higgins M; Quinones AM; Rosselli V; Canono E; Yoon C; Cattamanchi A; Davis JL; Phang T; Stearman RS; Datta G; Garcia BJ; Daley CL; Strong M; Kechris K; Fingerlin TE; Reves R; Geraci MW
J Clin Microbiol; 2016 Feb; 54(2):274-82. PubMed ID: 26582831
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of CD64 in patients with Mycobacterium tuberculosis infection: A potential biomarker for clinical diagnosis and prognosis.
Liu Q; Gao Y; Ou Q; Xu Y; Zhou Z; Li T; Lu Y; Sun F; Zhou X; Li Y; Shao L; Zhang W
J Cell Mol Med; 2020 Dec; 24(23):13961-13972. PubMed ID: 33164320
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
